Change in agglomeration status and toxicokinetic fate of various nanoparticles in vivo following lung exposure in rats

Inhalation Toxicology

Volumn 24, Issue 12, 2012, Pages 821-830

  Creutzenberg, Otto ^a   Bellmann, Bernd ^a   Korolewitz, Regina ^a   Koch, Wolfgang ^a   Mangelsdorf, Inge ^a   Tillmann, Thomas ^a   Schaudien, Dirk ^a  

^a FRAUNHOFER INSTITUTE FOR TOXICOLOGY AND EXPERIMENTAL MEDICINE   (Germany)

Author keywords

Agglomeration; Dispersion; in vivo; Nanoparticles; Translocation

Indexed keywords

CARBON; COPPER; NANOPARTICLE; NICKEL; PHOSPHATE BUFFERED SALINE; TITANIUM DIOXIDE;

AEROSOL; ANIMAL EXPERIMENT; ARTICLE; CELL INTERACTION; DISPERSION; IN VIVO STUDY; LUNG; LUNG LAVAGE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; RAT; RESPIRATORY SYSTEM; TOXICOKINETICS; TRANSMISSION ELECTRON MICROSCOPY;

ADMINISTRATION, INHALATION; AEROSOLS; ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; FEMALE; LUNG; MALE; METAL NANOPARTICLES; MICROSCOPY, ELECTRON, TRANSMISSION; NANOPARTICLES; PARTICLE SIZE; PARTICULATE MATTER; RATS; RATS, WISTAR; RESPIRATORY MUCOSA; RESPIRATORY SYSTEM; SOOT; SUSPENSIONS; TISSUE DISTRIBUTION; TITANIUM;

RATTUS;

EID: 84867188747     PISSN: 08958378     EISSN: 10917691     Source Type: Journal    
DOI: 10.3109/08958378.2012.721097     Document Type: Article

References (29)

1. Anjilvel S, Asgharian B. 1995. A multiple-path model of particle deposition in the rat lung. Fundam Appl Toxicol 28:41-50.
2. Bihari P, Vippola M, Schultes S, Praetner M, Khandoga AG, Reichel CA, Coester C, Tuomi T, Rehberg M, Krombach F. 2008. Optimized dispersion of nanoparticles for biological in vitro and in vivo studies. Part Fibre Toxicol 5:14.
3. Card JW, Zeldin DC, Bonner JC, Nestmann ER. 2008. Pulmonary applications and toxicity of engineered nanoparticles. Am J Physiol Lung Cell Mol Physiol 295:L400-L411.
4. Churg A. 1996. The uptake of mineral particles by pulmonary epithelial cells. Am J Respir Crit Care Med 154:1124-1140.
5. Creutzenberg O, Pohlmann G, Hansen T, Rittinghausen S, Ziemann C. 2009. Nano- and microscaled titanium dioxide: comparative study on the inflammatory and genotoxic effects after a 3-week inhalation in rats. Poster presentation at the 46th Congress of the European Societies of Toxicology (EUROTOX), Dresden, Germany, September 13-16, 2009.
6. Creutzenberg O. 2012. Biological interactions and toxicity of nanomaterials in the respiratory tract and various approaches of aerosol generation for toxicity testing. Arch Toxicol 86:1117-1122.
7. CRP. 1994. Human respiratory tract model for radiological protection. ICRP Publication 66. Ann ICRP 24:1-3.
8. Driscoll KE, Costa DL, Hatch G, Henderson R, Oberdorster G, Salem H, Schlesinger RB. 2000. Intratracheal instillation as an exposure technique for the evaluation of respiratory tract toxicity: uses and limitations. Toxicol Sci 55:24-35. (Pubitemid 30252432)
9. Elder A, Gelein R, Finkelstein JN, Driscoll KE, Harkema J, Oberdörster G. 2005. Effects of subchronically inhaled carbon black in three species. I. Retention kinetics, lung inflammation, and histopathology. Toxicol Sci 88:614-629. (Pubitemid 41672168)
10. Eydner M, Schaudien D, Creutzenberg O, Ernst H, Hansen T, Baumgärtner W, Rittinghausen S. 2012. Impacts after inhalationof nano- and fine-sized titanium dioxide particles: morphological changes, translocation within the rat lung, and evaluation of particle deposition using the relative deposition index. Inhal Toxicol 24:557-569.
11. Goebbert C, Hardinghaus F, Kampmann KH, Kroell M, Lehr C-M, Schäfer U, Schultze-Isfort C, Schultze C, Voetz M, Wohlleben W. 2009. Particle synthesis and characterisation. In: Kuhlbusch TAJ, Krug HF, Nau K, editors. NanoCare: health related aspects of nanomaterials - final scientific report, DECHEMA e.V., 9-21.
12. Henderson RF, Mauderly JL, Pickrell JA, Hahn FF, Muhle H, Rebar AH. 1987. Comparative study of bronchoalveolar lavage fluid: effect of species, age, and method of lavage. Exp Lung Res 13:329-342.
13. Ji Z, Jin X, George S, Xia T, Meng H, Wang X, Suarez E, Zhang H, Hoek EM, Godwin H, Nel AE, Zink JI. 2010. Dispersion and stability optimization of TiO2 nanoparticles in cell culture media. Environ Sci Technol 44:7309-7314.
14. Koch W. 1998. Application of aerosols. In: Uhlig S, Taylor AE, editors. Methods in pulmonary research. Basel-Boston-Berlin: Birkhäuser.
15. Limbach LK, Li Y, Grass RN, Brunner TJ, Hintermann MA, Muller M, Gunther D, Stark WJ. 2005. Oxide nanoparticle uptake in human lung fibroblasts: effects of particle size, agglomeration, and diffusion at low concentrations. Environ Sci Technol 39:9370-9376. (Pubitemid 41741229)
16. Maier M, Hannebauer B, Holldorff H, Albers P. 2006. Does lung surfactant promote disaggregation of nanostructured titanium dioxide? J Occup Environ Med 48:1314-1320. (Pubitemid 44967443)
17. Meissner T, Potthoff A, Richter V. 2009. Physico-chemical characterization in the light of toxicological effects. Inhal Toxicol 21 Suppl 1:35-39.
18. Mühlfeld C, Geiser M, Kapp N, Gehr P, Rothen-Rutishauser B. 2007. Re-evaluation of pulmonary titanium dioxide nanoparticle distribution using the "relative deposition index": Evidence for clearance through microvasculature. Part Fibre Toxicol 4:7.
19. OECD. 2010. Environment, Health and Safety Publications, Series on the Safety of Manufactured Nanomaterials No. 27, List of Manufactured Nanomaterials and List of Endpoints for Phase One of the Sponsorship Programme for the Testing of Manufactured Nanomaterials: Revision. Environment Directorate, ENV/JM/ MONO(2010)46.
20. Porter DW, Sriram K, Wolfarth M, Jefferson A, Schwegler-Berry D, Andrew M, Castranova V. 2008. A biocompatible medium for nanoparticle dispersion. Nanotox 2:144-154.
21. Rehn B, Seiler F, Rehn S, Bruch J, Maier M. 2003. Investigations on the inflammatory and genotoxic lung effects of two types of titanium dioxide: untreated and surface treated. Toxicol Appl Pharmacol 189:84-95. (Pubitemid 36638276)
22. Sager TM, Porter DW, Robinson VA, Lindsley WG, Schwegler-Berry DE, Castranova V. 2007. Improved method to disperse nanoparticles for in vitro and in vivo investigation of toxicity. Nanotoxicology 1:118-129. (Pubitemid 47344136)
23. Schaudien D, Knebel JW, Mangelsdorf I, Voss J-U, Koch W, Creutzenberg O. 2011. Dispersion and retention of dusts consisting of ultrafine primary particles in lungs. Available at: http://www.baua.de/de/Publikationen/ Fachbeitraege/F2133.pdf;jsessionid=993A7E89D5992C327276FCD75842DCF2.1-cid246?- blob=publicationFile&v=11.
24. Schaudien D, Knebel J, Creutzenberg O. 2012. In vitro study revealed different size behavior of different nanoparticles. J Nanoparticle Res 14:1039.
25. Schulze C, Kroll A, Lehr C-M, Schäfer UF, Becker K, Schnekenburger J, Schulze Isfort C, Landsiedel R, Wohlleben W. 2008. Not ready to use - overcoming pitfalls when dispersing nanoparticles in physiological media. Nanotoxicology 2:51-61.
26. Schulze C, Schaefer UF, Ruge CA, Wohlleben W, Lehr CM. 2011. Interaction of metal oxide nanoparticles with lung surfactant protein A. Eur J Pharm Biopharm 77:376-383.
27. Semmler-Behnke M, Takenaka S, Fertsch S, Wenk A, Seitz J, Mayer P, Oberdörster G, Kreyling WG. 2007. Efficient elimination of inhaled nanoparticles from the alveolar region: evidence for interstitial uptake and subsequent reentrainment onto airways epithelium. Environ Health Perspect 115:728-733. (Pubitemid 46785042)
28. US-EPA. 2010. Nanomaterial Case Studies: Nanoscale Titanium Dioxide in Water Treatment and in Topical Sunscreen. EPA/6700/ R-09/057F, November 2010.
29. Wong BA, Nash DG, Moss OR. 2009. Generation of nanoparticle agglomerates and their dispersion in lung serum stimulant or water. Inhaled particles X (23-25 September 2008, Manchester). J Phys Conference Series 151:012036. doi:10.1088/1742-6596/151/1/012036.